News

Novo Nordisk: The Pullback Is Noise - The Buy Case Is Stronger Than Ever
While Novo Nordisk stock has underperformed since my Strong Buy rating four months ago, the long-term investment thesis ...
WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care
WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the ...
Stocktwits on MSN1h
Wegovy for $299? Retail Buzz Erupts As WeightWatchers, Novo Nordisk Expand Obesity Drug Push
Retail chatter around WW International surged Tuesday after the company’s expanded collaboration with Novo Nordisk officially ...
How Novo Nordisk misread the US market for its weight loss sensation
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...